The nationwide study will assess the safety and efficacy of the technology that combines standard balloon dilation to open the nasal passageways with drug delivery designed to maintain symptom relief ...
NES ZIONA, Israel, Dec. 8, 2025 /PRNewswire/ -- EyeYon Medical Ltd., a global leader in ophthalmic innovation, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
The MarketWatch News Department was not involved in the creation of this content. PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ -- Aqua Medical, a company advancing Endoscopic Metabolic Restoration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback